Suppr超能文献

浆细胞样尿路上皮癌(PUC):影像学特征与组织病理学相关性

Plasmacytoid urothelial carcinoma (PUC): Imaging features with histopathological correlation.

作者信息

Chung Andrew D, Schieda Nicola, Flood Trevor A, Cagiannos Ilias, Mai Kien T, Malone Shawn, Morash Christopher, Hakim Shaheed W, Breau Rodney H

机构信息

Department of Medical Imaging; The Ottawa Hospital, University of Ottawa, Ottawa, ON, Canada.

Department of Anatomical Pathology; The Ottawa Hospital, University of Ottawa, Ottawa, ON, Canada.

出版信息

Can Urol Assoc J. 2017 Jan-Feb;11(1-2):E50-E57. doi: 10.5489/cuaj.3789. Epub 2017 Jan 12.

Abstract

INTRODUCTION

Plasmacytoid urothelial carcinoma (PUC) is a high-grade variant of conventional urothelial cell carcinoma. This study is the first to describe the imaging findings of PUC, which are previously unreported, using clinical and histopathological correlation.

METHODS

With internal review board approval, we identified 22 consecutive patients with PUC from 2007-2014. Clinical parameters, including age, gender, therapy, surgical margins, and long-term outcome, were recorded. Baseline imaging was reviewed by an abdominal radiologist who evaluated for tumour detectability/location/morphology, local staging, and presence/location of metastases. Pelvic peritoneal spread of tumour (defined as >5mm thick soft tissue spreading along fascial planes) was also evaluated. Followup imaging was reviewed for presence of local recurrence or metastases.

RESULTS

Median age at presentation was 74 years (range 51-86), with only three female patients. Imaging features of the primary tumour in this study were not unique for PUC. Muscle-invasive disease was present on pathology in 19/22 (86%) of tumours, with distant metastases in 2/22 (9%) at baseline imaging. Pelvic peritoneal spread of tumour was radiologically present in 4/20 (20%) at baseline. During followup, recurrent/residual tumour was documented in 16/22 (73%) patients and 7/16 (44%) patients eventually developed distant metastases. Median time to disease recurrence in patients who underwent curative surgery was three months (range 0-19).

CONCLUSIONS

PUC is an aggressive variant of urothelial carcinoma with poor prognosis. Pelvic peritoneal spread of tumour as thick sheets extending along fascial planes may represent a characteristic imaging finding of locally advanced PUC.

摘要

引言

浆细胞样尿路上皮癌(PUC)是传统尿路上皮细胞癌的一种高级别变异型。本研究首次利用临床与组织病理学相关性描述了PUC此前未被报道的影像学表现。

方法

经内部审查委员会批准,我们确定了2007年至2014年间连续的22例PUC患者。记录临床参数,包括年龄、性别、治疗、手术切缘和长期预后。由一名腹部放射科医生对基线影像进行评估,评估内容包括肿瘤的可检测性/位置/形态、局部分期以及转移灶的存在/位置。还评估了肿瘤的盆腔腹膜播散情况(定义为沿筋膜平面蔓延的厚度>5mm的软组织)。对随访影像进行复查,以确定是否存在局部复发或转移。

结果

就诊时的中位年龄为74岁(范围51 - 86岁),仅有3例女性患者。本研究中原发性肿瘤的影像学特征并非PUC所特有。19/22(86%)的肿瘤在病理检查中显示为肌层浸润性疾病,基线影像检查时有2/22(9%)出现远处转移。基线时,4/20(20%)在影像学上显示有肿瘤盆腔腹膜播散。随访期间,16/22(73%)的患者记录有复发/残留肿瘤,7/16(44%)的患者最终发生远处转移。接受根治性手术的患者疾病复发的中位时间为3个月(范围0 - 19个月)。

结论

PUC是尿路上皮癌的一种侵袭性变异型,预后较差。肿瘤沿筋膜平面呈厚层状的盆腔腹膜播散可能是局部晚期PUC的一种特征性影像学表现。

相似文献

1
Plasmacytoid urothelial carcinoma (PUC): Imaging features with histopathological correlation.
Can Urol Assoc J. 2017 Jan-Feb;11(1-2):E50-E57. doi: 10.5489/cuaj.3789. Epub 2017 Jan 12.
2
Plasmacytoid urothelial carcinoma of the bladder with extensive scrotal wall invasion.
Urol Ann. 2016 Jul-Sep;8(3):381-3. doi: 10.4103/0974-7796.184897.
3
Plasmacytoid urothelial carcinoma of the urinary bladder report of seven new cases.
Eur Urol. 2006 Nov;50(5):1111-4. doi: 10.1016/j.eururo.2005.12.047. Epub 2006 Jan 18.
5
European Association of Urology Guidelines on Primary Urethral Carcinoma-2020 Update.
Eur Urol Oncol. 2020 Aug;3(4):424-432. doi: 10.1016/j.euo.2020.06.003. Epub 2020 Jun 27.
6
[Plasmacytoid urothelial carcinoma of the urinary bladder: a clinicopathologic study of 16 cases].
Zhonghua Bing Li Xue Za Zhi. 2013 Jul;42(7):433-7. doi: 10.3760/cma.j.issn.0529-5807.2013.07.001.
7
Plasmacytoid urothelial carcinoma of the bladder metastatic to the stomach: a case report.
Case Rep Urol. 2012;2012:715951. doi: 10.1155/2012/715951. Epub 2012 Aug 16.
8
Plasmacytoid urothelial carcinoma of the urinary bladder: a case report and immunohistochemical study.
Pathol Res Pract. 2009;205(3):189-94. doi: 10.1016/j.prp.2008.09.004. Epub 2008 Nov 28.
9
Plasmacytoid Urothelial Carcinoma: An Unusual Variant That Warrants Aggressive Management and Critical Distinction on Transurethral Resections.
Arch Pathol Lab Med. 2019 Dec;143(12):1562-1567. doi: 10.5858/arpa.2018-0139-RS. Epub 2019 Mar 13.
10
Plasmacytoid Urothelial Carcinoma of Ureter with Retroperitoneal Metastasis: A Case Report.
Am J Case Rep. 2018 Feb 13;19:158-162. doi: 10.12659/ajcr.906679.

引用本文的文献

1
Multiparametric MRI Features of Plasmacytoid Urothelial Carcinoma of the Urinary Bladder.
Korean J Radiol. 2025 Sep;26(9):832-840. doi: 10.3348/kjr.2025.0419.
2
A case of plasmacytoid urothelial carcinoma with characteristic radiological findings.
Abdom Radiol (NY). 2025 Apr 11. doi: 10.1007/s00261-025-04940-w.
4
Pictorial review of multiparametric MRI in bladder urothelial carcinoma with variant histology: pearls and pitfalls.
Abdom Radiol (NY). 2024 Aug;49(8):2797-2811. doi: 10.1007/s00261-024-04397-3. Epub 2024 Jun 7.
5
Renal pelvis cancer with initial symptoms of malignant gastric outlet obstruction.
IJU Case Rep. 2023 Oct 5;6(6):475-478. doi: 10.1002/iju5.12652. eCollection 2023 Nov.
6
Plasmacytoid bladder cancer: a rare case report.
Ann Med Surg (Lond). 2023 Apr 11;85(5):1885-1887. doi: 10.1097/MS9.0000000000000374. eCollection 2023 May.
8
Outcomes of poorly differentiated and plasmacytoid variant bladder urothelial carcinoma.
BJUI Compass. 2021 Aug 27;3(1):62-67. doi: 10.1002/bco2.108. eCollection 2022 Jan.
9
Multiparametric magnetic resonance imaging of plasmacytoid urothelial carcinoma with histopathological correlation: A case report.
Radiol Case Rep. 2022 Apr 13;17(6):2155-2161. doi: 10.1016/j.radcr.2022.03.034. eCollection 2022 Jun.
10
Plasmacytoid urothelial carcinoma of the bladder: MRI features and their association with survival.
Urol Oncol. 2022 Mar;40(3):108.e1-108.e10. doi: 10.1016/j.urolonc.2021.09.017. Epub 2021 Nov 5.

本文引用的文献

1
HER2 Protein Overexpression and Gene Amplification in Plasmacytoid Urothelial Carcinoma of the Urinary Bladder.
Dis Markers. 2016;2016:8463731. doi: 10.1155/2016/8463731. Epub 2016 Mar 10.
2
CUA guidelines on the management of non-muscle invasive bladder cancer.
Can Urol Assoc J. 2015 Sep-Oct;9(9-10):E690-704. doi: 10.5489/cuaj.3320. Epub 2015 Oct 13.
3
Bladder malignancies on CT: the underrated role of CT in diagnosis.
AJR Am J Roentgenol. 2014 Aug;203(2):347-54. doi: 10.2214/AJR.13.12021.
4
Plasmacytoid bladder cancer: variant histology with aggressive behavior and a new mode of invasion along fascial planes.
Urology. 2014 May;83(5):1112-6. doi: 10.1016/j.urology.2013.12.035. Epub 2014 Feb 26.
6
Plasmacytoid urothelial carcinoma, a chemosensitive cancer with poor prognosis, and peritoneal carcinomatosis.
J Urol. 2013 May;189(5):1656-61. doi: 10.1016/j.juro.2012.11.084. Epub 2012 Nov 15.
7
Plasmacytoid carcinoma of the bladder: a urothelial carcinoma variant with a predilection for intraperitoneal spread.
J Urol. 2012 Mar;187(3):852-5. doi: 10.1016/j.juro.2011.10.145. Epub 2012 Jan 15.
8
Bladder cancer: evaluation of staging accuracy using dynamic MRI.
Clin Radiol. 2011 Dec;66(12):1140-5. doi: 10.1016/j.crad.2011.05.019. Epub 2011 Sep 14.
9
Factors influencing post-recurrence survival in bladder cancer following radical cystectomy.
BJU Int. 2012 Mar;109(6):846-54. doi: 10.1111/j.1464-410X.2011.10455.x. Epub 2011 Aug 4.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验